Similar articles

• Cancer chemotherapy in young children: challenges and solutions.

  Koren G, Schechter T. Koren G, et al. Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1091-2. doi: 10.1002/pbc.21349. Pediatr Blood Cancer. 2007. PMID: 17943958 Review.
• [Mycological extended surveillance of outpatient and inpatient children with malignant diseases during and after long-term polychemotherapy].

  Blaschke-Hellmessen R, Rönisch P, Birke I. Blaschke-Hellmessen R, et al. Kinderarztl Prax. 1986 Feb;54(2):99-102. Kinderarztl Prax. 1986. PMID: 3702232 German. No abstract available.
• Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.

  Moritz B, Eder J, Meister B, Heitger A. Moritz B, et al. Med Pediatr Oncol. 2001 Feb;36(2):283-9. doi: 10.1002/1096-911X(20010201)36:2<283::AID-MPO1066>3.0.CO;2-8. Med Pediatr Oncol. 2001. PMID: 11452936
• [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].

  Tang SQ, Huang DS, Wang JW, Feng C, Yang G. Tang SQ, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2006 Apr;8(2):93-6. Zhongguo Dang Dai Er Ke Za Zhi. 2006. PMID: 16613697 Chinese.
• Interleukin-1: therapeutic potential for solid tumors.

  Johnson CS. Johnson CS. Cancer Invest. 1993;11(5):600-8. doi: 10.3109/07357909309011679. Cancer Invest. 1993. PMID: 8402228 Review. No abstract available.